000 01511 a2200409 4500
005 20250513162141.0
264 0 _c19990513
008 199905s 0 0 eng d
022 _a1042-8194
024 7 _a10.3109/10428199809057608
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFederici, A B
245 0 0 _aThe role of von Willebrand factor in the hemostatic defect of acute promyelocytic leukemia.
_h[electronic resource]
260 _bLeukemia & lymphoma
_cNov 1998
300 _a491-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aBiopolymers
650 0 4 _aBlood Coagulation Tests
650 0 4 _aCysteine Endopeptidases
_xphysiology
650 0 4 _aEndopeptidases
_xphysiology
650 0 4 _aHemorrhagic Disorders
_xetiology
650 0 4 _aHumans
650 0 4 _aLeukemia, Promyelocytic, Acute
_xblood
650 0 4 _aMacromolecular Substances
650 0 4 _aModels, Biological
650 0 4 _aMolecular Weight
650 0 4 _aNeoplasm Proteins
_xphysiology
650 0 4 _aPancreatic Elastase
_xphysiology
650 0 4 _aPlasminogen Activators
_xphysiology
650 0 4 _aPlatelet Adhesiveness
650 0 4 _aTretinoin
_xpharmacology
650 0 4 _avon Willebrand Factor
_xchemistry
700 1 _aD'Amico, E A
773 0 _tLeukemia & lymphoma
_gvol. 31
_gno. 5-6
_gp. 491-9
856 4 0 _uhttps://doi.org/10.3109/10428199809057608
_zAvailable from publisher's website
999 _c9883715
_d9883715